amphetamine has been researched along with Psychoses in 137 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we examined the effects of clozapine and risperidone on amphetamine-induced striatal dopamine release in patients with psychotic disorders." | 9.09 | Effects of atypical antipsychotic drug treatment on amphetamine-induced striatal dopamine release in patients with psychotic disorders. ( Adler, CM; Breier, A; Elman, I; Malhotra, AK; Pickar, D; Su, TP; Weisenfeld, NI, 1999) |
| " Some dimensions of the schizophrenia syndrome in man can be mimicked in animals by the amphetamine (AMPH)-sensitization-induced psychosis model." | 7.88 | Schizophrenia dimension-specific antipsychotic drug action and failure in amphetamine-sensitized psychotic-like rats. ( Dere, E; Grömer, TW; Kornhuber, J; Müller, CP; Schindehütte, M; Uzuneser, TC; von Hörsten, S, 2018) |
| " In this study, we examined the effects of clozapine and risperidone on amphetamine-induced striatal dopamine release in patients with psychotic disorders." | 5.09 | Effects of atypical antipsychotic drug treatment on amphetamine-induced striatal dopamine release in patients with psychotic disorders. ( Adler, CM; Breier, A; Elman, I; Malhotra, AK; Pickar, D; Su, TP; Weisenfeld, NI, 1999) |
| "To review current evidence linking amphetamine use with aggression and to consider possible factors that might underlie this association." | 4.85 | Mechanisms underlying aggressive and hostile behavior in amphetamine users. ( Davis, P; Dawe, S; Lapworth, K; McKetin, R, 2009) |
| "Pretreatment with EECL demonstrated antipsychotic activity in mice, preventing amphetamine-, apomorphine-, and ketamine-induced schizophrenia-like symptoms, with 800 mg/kg being the most effective dose." | 4.12 | Pretreatment with Carpolobia lutea ethanol extract prevents schizophrenia-like behavior in mice models of psychosis. ( Abdulrahim, HA; Aderibigbe, AO; Bakre, AG; Ben-Azu, B; Ezurike, PU; Isibor, H; Omeiza, NA; Sowunmi, AA, 2022) |
| " Some dimensions of the schizophrenia syndrome in man can be mimicked in animals by the amphetamine (AMPH)-sensitization-induced psychosis model." | 3.88 | Schizophrenia dimension-specific antipsychotic drug action and failure in amphetamine-sensitized psychotic-like rats. ( Dere, E; Grömer, TW; Kornhuber, J; Müller, CP; Schindehütte, M; Uzuneser, TC; von Hörsten, S, 2018) |
| "Amphetamine use is a risk factor for psychosis, which imposes a substantial burden on society." | 1.72 | Risk of psychosis in illicit amphetamine users: a 10 year retrospective cohort study. ( Huang, CL; Lee, CW; Tsai, IJ, 2022) |
| "To explore the relationship between sleep deprivation and amphetamine-induced psychosis." | 1.72 | Sleep Deprivation & Amphetamine Induced Psychosis. ( Alshehri, MH; Bahanan, AO; Elag, KA; Shalaby, AS, 2022) |
| "The extrapyramidal side effect of catalepsy was tested based on the ability of the extracts to alter the duration of akinesia in mice placed on a vertical wrapped string." | 1.38 | Antipsychotic property of aqueous and ethanolic extracts of Lonchocarpus cyanescens (Schumach and Thonn.) Benth. (Fabaceae) in rodents. ( Shonibare, ET; Sonibare, MA; Umukoro, S, 2012) |
| "Treatment with pimavanserin, a selective serotonin 5-HT(2A) receptor inverse agonist, prevented 2,5-dimethoxy-4-iodoamphetamine hydrochloride-induced head twitches, reversed the augmented locomotor response to amphetamine, and normalized prepulse inhibition in mice with amyloid pathology." | 1.38 | Pimavanserin, a 5-HT2A receptor inverse agonist, reverses psychosis-like behaviors in a rodent model of Alzheimer's disease. ( Bonhaus, DW; McFarland, K; Price, DL, 2012) |
| "Asenapine was highly potent (active at 0." | 1.35 | Asenapine effects in animal models of psychosis and cognitive function. ( Azar, MR; Geyer, MA; Gold, L; Marston, HM; Martin, FD; Meltzer, LT; Moore, CL; Serpa, KA; Shahid, M; Wong, EH; Young, JW, 2009) |
| "Psychosis is linked to dysregulation of the neuromodulator dopamine and antipsychotic drugs (APDs) work by blocking dopamine receptors." | 1.34 | Linking animal models of psychosis to computational models of dopamine function. ( Becker, S; Kapur, S; Li, M; Smith, AJ, 2007) |
| "Priapism is a "persistent erection not accompanied by sexual desire or stimulation, usually lasting more than six hours and typically involving only the corpora cavernosa." | 1.33 | Priapism and quetiapine: a case report. ( Dilley, JW; Harrison, G; Loeb, L; Nelson, K, 2006) |
| "Xanomeline is a muscarinic M(1)/M(4) preferring receptor agonist with little or no affinity for dopamine receptors." | 1.32 | The muscarinic M1/M4 receptor agonist xanomeline exhibits antipsychotic-like activity in Cebus apella monkeys. ( Andersen, MB; Bymaster, F; Fink-Jensen, A; Gerlach, J; Lundbaek, JA; Peacock, L; Werge, T, 2003) |
| "Psychosis frequently occurs in Alzheimer's disease (AD), being associated with more severe cognitive decline, but the underlying mechanisms are unknown." | 1.32 | Beta-amyloid treatment sensitizes mice to amphetamine-induced locomotion but reduces response to caffeine. ( da Silva, AL; Dall'Igna, OP; Hoffmann, A; Lara, DR; Souza, DO, 2004) |
| "Pre-treatment with verapamil (10 and 20 mg/kg, i." | 1.31 | Behavioural and anti-psychotic effects of Ca2+ channel blockers in rhesus monkey. ( Dubey, MP; Kalsotra, A; Kumar, R; Nath, C; Palit, G, 2001) |
| "Treatment with amphetamine induced decrease of GAP-43 mRNA expression, that was detected also during recovery period, up to 14 days after the last day of 7 days treatments." | 1.31 | Differential effects of amphetamine and phencyclidine on the expression of growth-associated protein GAP-43. ( Kanazir, S; Rakic, L; Ruzdijic, S; Veskov, R; Vukosavic, S, 2001) |
| "Amphetamine psychosis has been considered to be a pharmacologic model of schizophrenia." | 1.26 | Amphetamine psychosis and psychotic symptoms. ( Janowsky, DS; Risch, C, 1979) |
| "In many organic psychoses, including psychosis due to ingestion of an atropine-like drug, use of anti-psychotic drug should be avoided." | 1.25 | Psychotropic drugs in the management of psychiatric emergencies. ( Ketai, R, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 93 (67.88) | 18.7374 |
| 1990's | 5 (3.65) | 18.2507 |
| 2000's | 16 (11.68) | 29.6817 |
| 2010's | 15 (10.95) | 24.3611 |
| 2020's | 8 (5.84) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, CL | 1 |
| Tsai, IJ | 1 |
| Lee, CW | 1 |
| Omeiza, NA | 1 |
| Bakre, AG | 1 |
| Abdulrahim, HA | 1 |
| Isibor, H | 1 |
| Ezurike, PU | 1 |
| Sowunmi, AA | 1 |
| Ben-Azu, B | 1 |
| Aderibigbe, AO | 1 |
| Herbst, C | 1 |
| O'Connell, M | 1 |
| Melton, BL | 1 |
| Moeller, KE | 1 |
| Shalaby, AS | 2 |
| Bahanan, AO | 2 |
| Alshehri, MH | 2 |
| Elag, KA | 1 |
| Babina, A | 1 |
| Sokolova, I | 1 |
| Vysotskyi, M | 1 |
| Badr Nassar, OM | 1 |
| Nasr Abou Elzahab, NF | 1 |
| Vojtechova, I | 1 |
| Tuckova, K | 1 |
| Juza, R | 1 |
| Stuchlik, A | 1 |
| Kelemen, E | 1 |
| Korabecny, J | 1 |
| Soukup, O | 1 |
| Petrasek, T | 1 |
| Weidenauer, A | 1 |
| Bauer, M | 1 |
| Sauerzopf, U | 1 |
| Bartova, L | 1 |
| Nics, L | 1 |
| Pfaff, S | 1 |
| Philippe, C | 1 |
| Berroterán-Infante, N | 1 |
| Pichler, V | 1 |
| Meyer, BM | 1 |
| Rabl, U | 1 |
| Sezen, P | 1 |
| Cumming, P | 1 |
| Stimpfl, T | 1 |
| Sitte, HH | 1 |
| Lanzenberger, R | 1 |
| Mossaheb, N | 1 |
| Zimprich, A | 1 |
| Rusjan, P | 1 |
| Dorffner, G | 1 |
| Mitterhauser, M | 1 |
| Hacker, M | 1 |
| Pezawas, L | 1 |
| Kasper, S | 1 |
| Wadsak, W | 1 |
| Praschak-Rieder, N | 1 |
| Willeit, M | 1 |
| Rajagopal, L | 1 |
| Kwon, S | 1 |
| Huang, M | 1 |
| Michael, E | 1 |
| Bhat, L | 1 |
| Cantillon, M | 1 |
| Meltzer, HY | 1 |
| Sara, G | 1 |
| Baxter, C | 1 |
| Menendez, P | 1 |
| Lappin, J | 1 |
| Uzuneser, TC | 1 |
| Schindehütte, M | 1 |
| Dere, E | 1 |
| von Hörsten, S | 1 |
| Kornhuber, J | 1 |
| Grömer, TW | 1 |
| Müller, CP | 1 |
| Cortese, S | 1 |
| Bao, YP | 1 |
| Qiu, Y | 1 |
| Yan, SY | 1 |
| Jia, ZJ | 1 |
| Li, SX | 1 |
| Lian, Z | 1 |
| Mu, Y | 1 |
| Liu, ZM | 1 |
| Hubbard, D | 1 |
| Hacksell, U | 1 |
| McFarland, K | 3 |
| Canal, CE | 1 |
| Morgan, D | 1 |
| Felsing, D | 1 |
| Kondabolu, K | 1 |
| Rowland, NE | 1 |
| Robertson, KL | 1 |
| Sakhuja, R | 1 |
| Booth, RG | 1 |
| Zhang, Y | 1 |
| Xu, Z | 1 |
| Zhang, S | 1 |
| Desrosiers, A | 1 |
| Schottenfeld, RS | 1 |
| Chawarski, MC | 1 |
| Ahn, KH | 1 |
| Sewell, A | 1 |
| Elander, J | 1 |
| Pittman, B | 1 |
| Ranganathan, M | 1 |
| Gunduz-Bruce, H | 1 |
| Krystal, J | 1 |
| D'Souza, DC | 1 |
| Merrill, RM | 1 |
| Thygerson, SM | 1 |
| Palmer, CA | 1 |
| Pałucha-Poniewiera, A | 1 |
| Kłodzińska, A | 1 |
| Stachowicz, K | 1 |
| Tokarski, K | 1 |
| Hess, G | 1 |
| Schann, S | 1 |
| Frauli, M | 1 |
| Neuville, P | 1 |
| Pilc, A | 1 |
| SCHNECK, JM | 1 |
| Dawe, S | 1 |
| Davis, P | 1 |
| Lapworth, K | 1 |
| McKetin, R | 1 |
| Chen, CY | 1 |
| Lin, KM | 1 |
| Marston, HM | 1 |
| Young, JW | 1 |
| Martin, FD | 1 |
| Serpa, KA | 1 |
| Moore, CL | 1 |
| Wong, EH | 1 |
| Gold, L | 1 |
| Meltzer, LT | 1 |
| Azar, MR | 1 |
| Geyer, MA | 1 |
| Shahid, M | 1 |
| Arad, M | 1 |
| Weiner, I | 1 |
| SEREISKII, MY | 1 |
| Sonibare, MA | 1 |
| Umukoro, S | 1 |
| Shonibare, ET | 1 |
| Price, DL | 2 |
| Bonhaus, DW | 2 |
| Waters, KA | 1 |
| Stean, TO | 1 |
| Hammond, B | 1 |
| Virley, DJ | 1 |
| Upton, N | 1 |
| Kew, JN | 1 |
| Hussain, I | 1 |
| Andersen, MB | 1 |
| Fink-Jensen, A | 1 |
| Peacock, L | 1 |
| Gerlach, J | 1 |
| Bymaster, F | 1 |
| Lundbaek, JA | 1 |
| Werge, T | 1 |
| ALLIEZ, J | 2 |
| BARUK, H | 1 |
| JOUBERT, P | 1 |
| POTTIER, C | 1 |
| GEORGELIN, R | 1 |
| DU COUEDIC, H | 1 |
| SAVY, A | 1 |
| CHAPMAN, AH | 1 |
| CARR, RB | 1 |
| DELAY, J | 2 |
| PICHOT, P | 2 |
| LEMPERIERE, T | 1 |
| SADOUN, R | 1 |
| FISCHER, R | 2 |
| SCHINKO, H | 1 |
| SOLMS, W | 1 |
| ZEH, W | 1 |
| ROPERT, R | 1 |
| BHASKARAN, K | 1 |
| SIMPSON, WS | 1 |
| BLACKMAN, LH | 2 |
| GLENN, A | 2 |
| OLINGER, L | 2 |
| LANDO, SF | 1 |
| CAHN, J | 2 |
| HEROLD, M | 2 |
| DUBRASQUET, M | 2 |
| BARRE, N | 2 |
| ALANO, J | 2 |
| BRETON, Y | 2 |
| FERRERO, RG | 1 |
| TATETSU, S | 1 |
| YOUNG, GG | 1 |
| SIMSON, CB | 1 |
| FROHMAN, CE | 1 |
| BEAMISH, P | 1 |
| KILOH, LG | 1 |
| ELST, E | 1 |
| FISH, CH | 1 |
| BOWLING, E | 1 |
| GIBERTI, F | 1 |
| ROSSI, R | 1 |
| CHARALAMPOUS, KD | 1 |
| HUG, A | 1 |
| MURRAY, PA | 1 |
| PROUT, CT | 1 |
| SHULGIN, AT | 1 |
| MCDONALD, RL | 1 |
| GUDMUNDSSON, G | 1 |
| WEINER, IB | 1 |
| LYNN, GE | 1 |
| LUDWIG, AM | 1 |
| LEVINE, J | 1 |
| CLANCY, J | 1 |
| BELL, DS | 1 |
| NEUENSCHWANDER, F | 1 |
| O'FLANAGAN, PM | 1 |
| TAYLOR, RB | 1 |
| WALTHER, R | 1 |
| WALLIS, GG | 1 |
| McHARG, JF | 1 |
| SCOTT, OC | 1 |
| KALUS, F | 2 |
| DENIKER, P | 2 |
| Marona-Lewicka, D | 1 |
| Thisted, RA | 1 |
| Nichols, DE | 1 |
| Dall'Igna, OP | 2 |
| Tort, AB | 1 |
| Souza, DO | 2 |
| Lara, DR | 2 |
| Smith, AJ | 1 |
| Li, M | 1 |
| Becker, S | 1 |
| Kapur, S | 1 |
| Hoffmann, A | 1 |
| da Silva, AL | 1 |
| Harrison, G | 1 |
| Dilley, JW | 1 |
| Loeb, L | 1 |
| Nelson, K | 1 |
| Stasi, MA | 1 |
| Di Serio, S | 1 |
| Vertechy, M | 1 |
| Schiavone, A | 1 |
| Ghirardi, O | 1 |
| Minetti, P | 1 |
| Campiani, G | 1 |
| Borsini, F | 1 |
| Carminati, P | 1 |
| VILA, G | 1 |
| Galici, R | 1 |
| Boggs, JD | 1 |
| Miller, KL | 1 |
| Bonaventure, P | 1 |
| Atack, JR | 1 |
| Varga, E | 1 |
| Tringer, L | 1 |
| Blundell, JE | 1 |
| Tombros, E | 1 |
| Rogers, PJ | 1 |
| Latham, CJ | 1 |
| Luchins, DJ | 1 |
| Monroe, RR | 1 |
| Ridley, RM | 1 |
| Baker, HF | 1 |
| Castner, SA | 1 |
| Goldman-Rakic, PS | 1 |
| Breier, A | 1 |
| Su, TP | 1 |
| Malhotra, AK | 1 |
| Elman, I | 1 |
| Adler, CM | 1 |
| Weisenfeld, NI | 1 |
| Pickar, D | 1 |
| Karcz-Kubicha, M | 1 |
| Wedzony, K | 1 |
| Zajaczkowski, W | 1 |
| Danysz, W | 1 |
| Palit, G | 1 |
| Kalsotra, A | 1 |
| Kumar, R | 1 |
| Nath, C | 1 |
| Dubey, MP | 1 |
| Martinez, D | 1 |
| Gelernter, J | 1 |
| Abi-Dargham, A | 1 |
| van Dyck, CH | 1 |
| Kegeles, L | 1 |
| Innis, RB | 1 |
| Laruelle, M | 1 |
| Vukosavic, S | 1 |
| Ruzdijic, S | 1 |
| Veskov, R | 1 |
| Rakic, L | 1 |
| Kanazir, S | 1 |
| Selten, JP | 1 |
| Bosman, IJ | 1 |
| de Boer, D | 1 |
| Veen, ND | 1 |
| van der Graaf, Y | 1 |
| Maes, RA | 1 |
| Kahn, RS | 1 |
| Sathananthan, GL | 1 |
| Sanghvi, I | 1 |
| Phillips, N | 1 |
| Gershon, S | 3 |
| Hornykiewicz, O | 1 |
| Colpaert, FC | 1 |
| Niemegeers, CJ | 2 |
| Janssen, PA | 3 |
| Janowsky, DS | 2 |
| Risch, C | 1 |
| Randrup, A | 4 |
| Munkvad, I | 4 |
| Ketai, R | 1 |
| Satel, SL | 1 |
| Seibyl, JP | 1 |
| Charney, DS | 1 |
| Mueser, KT | 1 |
| Yarnold, PR | 1 |
| Levinson, DF | 1 |
| Singh, H | 1 |
| Bellack, AS | 1 |
| Kee, K | 1 |
| Morrison, RL | 1 |
| Yadalam, KG | 1 |
| Jefferson, JW | 1 |
| Angrist, B | 1 |
| Schellekens, KH | 1 |
| Dresse, A | 1 |
| Lenaerts, FM | 1 |
| Pinchard, A | 1 |
| Schaper, WK | 1 |
| van Nueten, JM | 1 |
| Verbruggen, FJ | 1 |
| Ball, JR | 1 |
| Enelow, AJ | 1 |
| Davis, JM | 1 |
| Dalai, O | 1 |
| Friedhoff, AJ | 2 |
| Alpert, M | 1 |
| Bender, L | 1 |
| Waldmann, H | 1 |
| Anokhina, IP | 1 |
| Zabrodin, GD | 1 |
| Svirinovskiĭ, IaE | 1 |
| Johnston, VS | 2 |
| Bradley, RJ | 2 |
| Winslow, WW | 1 |
| Stone, WN | 1 |
| Hofling, CK | 1 |
| Brodsky, L | 1 |
| Vinar, O | 1 |
| Vojtík, V | 1 |
| Chundela, B | 1 |
| Westermeyer, J | 1 |
| Serposs, A | 1 |
| Bowers, MB | 1 |
| Kupernik, K | 1 |
| Wieder, H | 1 |
| Kaplan, EH | 1 |
| Jovanović, UJ | 1 |
| Langen, D | 1 |
| Bourgeois, M | 2 |
| Vincent, JD | 2 |
| Favarel-Garrigues, B | 2 |
| Angrist, BM | 1 |
| Schweitzer, JW | 1 |
| Arnold, OH | 1 |
| Collard, J | 1 |
| Ginestet, D | 1 |
| Hippius, H | 1 |
| Itil, TM | 1 |
| Labhardt, F | 1 |
| Leeds, AA | 1 |
| Montanini, R | 1 |
| Morozov, G | 1 |
| Simon, P | 1 |
| Villeneuve, A | 1 |
| Van Rossum, JM | 1 |
| Boissier, JR | 1 |
| Julou, L | 1 |
| Loew, DM | 1 |
| Moller Nielsen, I | 1 |
| Stille, G | 1 |
| Tedeschi, DH | 1 |
| Lehmann, HE | 1 |
| Ban, TA | 1 |
| Kral, VA | 1 |
| Bewley, TH | 1 |
| Ben-Arie, O | 1 |
| Prokop, H | 1 |
| Smythies, JR | 1 |
| Abenson, MH | 1 |
| Johnson, J | 1 |
| Milner, G | 1 |
14 reviews available for amphetamine and Psychoses
| Article | Year |
|---|---|
Captagone & Morbid Jealousy.
Topics: Adolescent; Adult; Amphetamine; Humans; Jealousy; Male; Middle Aged; Psychotic Disorders; Schizophre | 2023 |
Mechanisms underlying aggressive and hostile behavior in amphetamine users.
Topics: Aggression; Amphetamine; Disruptive, Impulse Control, and Conduct Disorders; Hostility; Humans; Para | 2009 |
Health consequences of illegal drug use.
Topics: Amphetamine; Depressive Disorder; Health Status; Hepatitis C; Humans; Illicit Drugs; Marijuana Abuse | 2009 |
DIFFERENTIAL DIAGNOSIS IN AMPHETAMINE PSYCHOSIS.
Topics: Amphetamine; Amphetamines; Diagnosis, Differential; Humans; Mental Disorders; Personality; Personali | 1964 |
Stereotypy in monkeys and humans.
Topics: Amphetamine; Animals; Callithrix; Child; Chlorocebus aethiops; Cognition; Dopamine; Haplorhini; Huma | 1982 |
Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
Topics: Adenylyl Cyclase Inhibitors; Amphetamine; Animals; Antipsychotic Agents; Brain Chemistry; Cats; Corp | 1977 |
Stereotyped behavior.
Topics: Amphetamine; Animals; Behavior; Birds; Cats; Chickens; Columbidae; Conditioning, Operant; Corpus Str | 1975 |
Beta-adrenergic receptor blocking drugs in psychiatry.
Topics: Acute Disease; Adrenergic beta-Antagonists; Alcoholism; Amphetamine; Animals; Antidepressive Agents; | 1974 |
Dopamine and psychotic states: preliminary remarks.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Carbon Radioisotopes; Cats; Cocaine; Dihydroxyp | 1974 |
The use and abuse of the psychotropic drugs.
Topics: Adult; Amphetamine; Antidepressive Agents; Anxiety; Chlorpromazine; Depression; Drug Utilization; Fe | 1973 |
Molecular pharmacology of hallucinogens.
Topics: Amphetamine; Animals; Avoidance Learning; Brain; Conditioning, Operant; Emotions; Hallucinogens; Hum | 1968 |
Drug therapy.
Topics: Amphetamine; Antidepressive Agents; Chlorpromazine; Chlorprothixene; Clinical Trials as Topic; Hallu | 1967 |
Pharmacological studies on the brain mechanisms underlying two forms of behavioral excitation: stereotyped hyperactivity and "rage".
Topics: Aggression; Amphetamine; Anger; Animals; Basal Ganglia; Behavior, Animal; Brain; Brain Chemistry; Di | 1969 |
A biochemical survey of schizophrenia.
Topics: Amines; Amphetamine; Antibodies; Antigen-Antibody Reactions; Antimetabolites; Biotransformation; Blo | 1970 |
7 trials available for amphetamine and Psychoses
| Article | Year |
|---|---|
Role of GABA Deficit in Sensitivity to the Psychotomimetic Effects of Amphetamine.
Topics: Adolescent; Adult; Amphetamine; Cross-Over Studies; Double-Blind Method; Drug Administration Schedul | 2015 |
Effects of atypical antipsychotic drug treatment on amphetamine-induced striatal dopamine release in patients with psychotic disorders.
Topics: Adult; Amphetamine; Antipsychotic Agents; Clozapine; Dopamine Antagonists; Dopamine Uptake Inhibitor | 1999 |
MJ 9022: correlation between neuroleptic potential and stereotypy.
Topics: Amphetamine; Animals; Antipsychotic Agents; Behavior; Clinical Trials as Topic; Dogs; Drug Interacti | 1975 |
Beta-adrenergic receptor blocking drugs in psychiatry.
Topics: Acute Disease; Adrenergic beta-Antagonists; Alcoholism; Amphetamine; Animals; Antidepressive Agents; | 1974 |
Dopamine, psychomotor stimulants, and schizophrenia: effects of methylphenidate and the stereoisomers of amphetamine in schizophrenics.
Topics: Amphetamine; Behavior; Clinical Trials as Topic; Dextroamphetamine; Dopamine; Humans; Methylphenidat | 1974 |
Drug therapy.
Topics: Amphetamine; Antidepressive Agents; Chlorpromazine; Chlorprothixene; Clinical Trials as Topic; Hallu | 1967 |
Psychological tests: practice effect in geriatric patients.
Topics: Aged; Amobarbital; Amphetamine; Carbon Dioxide; Female; Humans; Male; Mental Disorders; Middle Aged; | 1968 |
118 other studies available for amphetamine and Psychoses
| Article | Year |
|---|---|
Risk of psychosis in illicit amphetamine users: a 10 year retrospective cohort study.
Topics: Amphetamine; Cohort Studies; Female; Humans; Illicit Drugs; Psychotic Disorders; Retrospective Studi | 2022 |
Pretreatment with Carpolobia lutea ethanol extract prevents schizophrenia-like behavior in mice models of psychosis.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Ethanol; Ketamine; Male; Mice; Plant Extrac | 2022 |
Initiation of Antipsychotic Treatment for Amphetamine Induced Psychosis and Its Impact on Length of Stay.
Topics: Adult; Amphetamine; Antipsychotic Agents; Humans; Length of Stay; Psychotic Disorders; Retrospective | 2023 |
Sleep Deprivation & Amphetamine Induced Psychosis.
Topics: Amphetamine; Amphetamine-Related Disorders; Humans; Psychoses, Substance-Induced; Psychotic Disorder | 2022 |
Characteristics of Amphetamine Psychosis with Respect to the Length of Drug Exposure.
Topics: Amphetamine; Humans; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders; Substance-R | 2023 |
Dopaminergic and glutamatergic models of psychosis show differential sensitivity to aripiprazole and a novel experimental compound modulating D
Topics: Amphetamine; Animals; Antipsychotic Agents; Aripiprazole; Dizocilpine Maleate; Dopamine; Dose-Respon | 2023 |
On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D
Topics: Amphetamine; Dopamine; Female; Humans; Pharmaceutical Preparations; Prospective Studies; Psychotic D | 2020 |
RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia.
Topics: Amphetamine; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Cerebral Cortex; Cond | 2017 |
Amphetamine availability predicts amphetamine-related mental health admissions: A time series analysis.
Topics: Amphetamine; Amphetamine-Related Disorders; Australia; Crime; Hospitalization; Humans; Psychoses, Su | 2018 |
Schizophrenia dimension-specific antipsychotic drug action and failure in amphetamine-sensitized psychotic-like rats.
Topics: Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Brain; Disease Models, Animal; Dose-Re | 2018 |
Psychosis during Attention Deficit-Hyperactivity Disorder Treatment with Stimulants.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Human | 2019 |
Pattern of drug use and depressive symptoms among amphetamine type stimulants users in Beijing and Guangdong province, China.
Topics: Adult; Alcohol Drinking; Amphetamine; Central Nervous System Stimulants; China; Comorbidity; Cross-S | 2013 |
Behavioral effects of clozapine, pimavanserin, and quetiapine in rodent models of Parkinson's disease and Parkinson's disease psychosis: evaluation of therapeutic ratios.
Topics: Amphetamine; Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Clozapine; Dopamine; | 2013 |
A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.
Topics: 2-Naphthylamine; Amphetamine; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Feed | 2014 |
Profiles of psychiatric symptoms among amphetamine type stimulant and ketamine using inpatients in Wuhan, China.
Topics: Adult; Amphetamine; Analgesics; Central Nervous System Stimulants; China; Female; Humans; Inpatients | 2014 |
Risk of Injury According to Attention Deficit Hyperactivity Disorder, Comorbid Mental Illness, and Medication Therapy.
Topics: Adolescent; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperacti | 2016 |
Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents.
Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Cyclopentanes; Disease M | 2008 |
Benzedrine psychosis; report of a case.
Topics: Amphetamine; Central Nervous System Agents; Humans; Mental Disorders; Psychotic Disorders | 1948 |
Asenapine effects in animal models of psychosis and cognitive function.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Attention; Benzodiazepines; Cognition; Dibe | 2009 |
Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis?
Topics: Amphetamine; Animals; Antipsychotic Agents; Clozapine; Disease Models, Animal; Dopamine; Dopamine Up | 2010 |
Use of amphetamine in mental diseases.
Topics: Amphetamine; Amphetamines; Mental Disorders; Psychotic Disorders | 1946 |
Antipsychotic property of aqueous and ethanolic extracts of Lonchocarpus cyanescens (Schumach and Thonn.) Benth. (Fabaceae) in rodents.
Topics: Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Catalepsy; Chlorpromazine; Chromatogra | 2012 |
Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease.
Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System S | 2011 |
Effects of the selective 5-HT(7) receptor antagonist SB-269970 in animal models of psychosis and cognition.
Topics: Amphetamine; Animals; Animals, Outbred Strains; Cognition; Disease Models, Animal; Fluorobenzenes; L | 2012 |
Pimavanserin, a 5-HT2A receptor inverse agonist, reverses psychosis-like behaviors in a rodent model of Alzheimer's disease.
Topics: Alzheimer Disease; Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Disea | 2012 |
The muscarinic M1/M4 receptor agonist xanomeline exhibits antipsychotic-like activity in Cebus apella monkeys.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Cebus; Male; Muscarinic Agonists; Psychotic | 2003 |
[Amphetamine delirium].
Topics: Amphetamine; Amphetamines; Delirium; Humans; Mental Disorders; Psychoses, Substance-Induced; Psychot | 1953 |
[Therapeutic effects and hazards of amphetamine or psychotonic amines; drug addiction and hallucinatory delusions caused by orthedrine].
Topics: Amines; Amphetamine; Amphetamine-Related Disorders; Amphetamines; Delusions; Hallucinations; Humans; | 1953 |
[Hallucination psychoses due to amphetamine poisoning].
Topics: Amphetamine; Central Nervous System Agents; Hallucinations; Humans; Mental Disorders; Psychotic Diso | 1953 |
[Symptomatic manias and recent therapies].
Topics: Adrenocorticotropic Hormone; Amphetamine; Amphetamines; Bipolar Disorder; Cortisone; Humans; Mental | 1954 |
Paranoid psychoses associated with amphetamine usage; a clinical note.
Topics: Amphetamine; Amphetamines; Humans; Paranoid Disorders; Psychoses, Substance-Induced; Psychotic Disor | 1954 |
Acute psychotic reaction after inhaling methylamphetamine.
Topics: Amphetamine; Amphetamines; Humans; Mental Disorders; Methamphetamine; Psychoses, Substance-Induced; | 1954 |
[Amphetamine psychoses and pseudo-psychoses].
Topics: Amphetamine; Amphetamines; Humans; Mental Disorders; Psychoses, Substance-Induced; Psychotic Disorde | 1954 |
Factors involved in drug-produced model psychoses.
Topics: Amphetamine; Amphetamines; Animals; Ergot Alkaloids; Hallucinations; Humans; Mental Disorders; Phene | 1954 |
[A psychosis in adipex addiction].
Topics: Amphetamine; Amphetamines; Behavior, Addictive; Humans; Psychoses, Substance-Induced; Psychotic Diso | 1954 |
Factors involved in drug-produced model psychoses.
Topics: Amphetamine; Amphetamines; Animals; Ergot Alkaloids; Mental Disorders; Phenethylamines; Psychoses, S | 1954 |
[A Halloo-Wach psychosis; maintenance of toxic psychosis by constant excitation].
Topics: Amphetamine; Amphetamines; Humans; Mental Disorders; Psychoses, Substance-Induced; Psychotic Disorde | 1955 |
[Amphetamine shock: its diagnostic use and therapeutic value].
Topics: Amphetamine; Amphetamines; Convulsive Therapy; Electroconvulsive Therapy; Humans; Psychosurgery; Psy | 1957 |
Experiences with sodium amytalmethedrine combination as a communication-facilitant.
Topics: Amobarbital; Amphetamine; Amphetamines; Communication; Counseling; Humans; Psychotic Disorders; Sodi | 1957 |
Toxic psychosis; a complication of overdosage of anti-obesity drugs.
Topics: Amphetamine; Amphetamines; Anti-Obesity Agents; Humans; Mental Disorders; Obesity; Psychoses, Substa | 1957 |
The use of vitarespital in the treatment of elderly psychotic patients.
Topics: Amphetamine; Amphetamines; Dementia; Humans; Mental Disorders; Psychotic Disorders; Reserpine; Vitam | 1958 |
Chlorpromazine and dextroamphetamine (dexedrine) in psychiatric patients.
Topics: Amphetamine; Amphetamines; Chlorpromazine; Dextroamphetamine; Electroconvulsive Therapy; Psychosurge | 1958 |
The combination of tranquilizer, sympathomimetic drug and vitamins in the treatment of elderly psychotic patients.
Topics: Amphetamine; Amphetamines; Dementia; Humans; Hypnotics and Sedatives; Mental Disorders; Psychotic Di | 1958 |
[Contribution to a biochemical concept of experimental psychoses. VIII. Effect of iproniazid (marsilid), desoxyephedrine (pervitin) & lysergic acid diethylamide on blood & cerebral metabolism in the conscious rabbit].
Topics: Amphetamine; Amphetamines; Animals; Biochemical Phenomena; Brain; Consciousness; Iproniazid; Lysergi | 1958 |
[Study of a biochemical concept of experimental psychoses. IX. Effect of prolonged administration of desoxyephedrine (pervitine) and iproniazid (marsilid) on body fluid balance and cerebral metabolism of the waking rabbit].
Topics: Amphetamine; Amphetamines; Animals; Body Fluids; Brain; Iproniazid; Methamphetamine; Niacin; Nicotin | 1958 |
[Toxicomanias caused by psychostimulating drugs].
Topics: Amphetamine; Amphetamines; Humans; Hydrazines; Mental Disorders; Psychoses, Substance-Induced; Psych | 1960 |
[Pervitin psychoses].
Topics: Amphetamine; Amphetamines; Mental Disorders; Psychotic Disorders | 1960 |
Clinical and biochemical studies of an amphetamine withdrawal psychosis.
Topics: Amphetamine; Amphetamine-Related Disorders; Amphetamines; Humans; Mental Disorders; Psychotic Disord | 1961 |
Psychoses due to amphetamine consumption.
Topics: Amphetamine; Amphetamines; Humans; Mental Disorders; Psychoses, Substance-Induced; Psychotic Disorde | 1960 |
[Amphetamine psychoses].
Topics: Amphetamine; Amphetamines; Humans; Mental Disorders; Psychotic Disorders | 1959 |
Effect of amphetamines on speech defects in the mentally retarded.
Topics: Amphetamine; Aphasia; Cleft Palate; Deafness; Dextroamphetamine; Double-Blind Method; Humans; Intell | 1962 |
Proposal of a psychopharmacological test ("stimulation threshold") for differentiating neurotic from psychotic depressions. Preliminary report.
Topics: Amphetamine; Amphetamines; Bipolar Disorder; Depression; Depressive Disorder; Humans; Psychotic Diso | 1962 |
Psychosis following the use of amphetamines.
Topics: Amphetamine; Amphetamines; Humans; Mental Disorders; Psychoses, Substance-Induced; Psychotic Disorde | 1963 |
SYMPATHOMIMETIC DRUG-INDUCED PSYCHOSIS.
Topics: Amphetamine; Amphetamines; Appetite Depressants; Paranoid Disorders; Psychoses, Substance-Induced; P | 1964 |
REACTIONS TO USE OF AMPHETAMINES AS OBSERVED IN A PSYCHIATRIC HOSPITAL.
Topics: Alcoholism; Amobarbital; Amphetamine; Amphetamines; Barbiturates; Dextroamphetamine; Hospitals, Psyc | 1964 |
3-METHOXY-4,5-METHYLENEDIOXY AMPHETAMINE, A NEW PSYCHOTOMIMETIC AGENT.
Topics: Amphetamine; Amphetamines; Dogs; Hallucinogens; Mental Disorders; Mescaline; Mice; Oils; Oils, Volat | 1964 |
IATROGENIC AMPHETAMINE PSYCHOSIS.
Topics: Amphetamine; Amphetamines; Electroconvulsive Therapy; Iatrogenic Disease; Niacinamide; Phenothiazine | 1964 |
[AMPHETAMINE PSYCHOSES].
Topics: Amphetamine; Amphetamines; Humans; Mental Disorders; Psychoses, Substance-Induced; Psychotic Disorde | 1964 |
PSYCHOPHARMACOLOGIC SURVEY OF PSYCHIATRIC REFERRALS.
Topics: Amphetamine; Drug Therapy; Emotions; Hypnotics and Sedatives; Mental Disorders; Narcotics; Psychopha | 1964 |
PATTERNS OF HALLUCINOGENIC DRUG ABUSE.
Topics: Amphetamine; Amphetamines; Barbiturates; Cannabis; Drug and Narcotic Control; Hallucinogens; Humans; | 1965 |
OTHER ASPECTS OF DEPRESSION.
Topics: Alcoholism; Amphetamine; Antidepressive Agents; Barbiturates; Bipolar Disorder; Brain Diseases; Depr | 1965 |
COMPARISON OF AMPHETAMINE PSYCHOSIS AND SCHIZOPHRENIA.
Topics: Amphetamine; Amphetamines; Diagnosis, Differential; Hallucinations; Hallucinogens; Humans; Paranoid | 1965 |
[Psychoses due to amphetamine abuse].
Topics: Amphetamine; Amphetamine-Related Disorders; Amphetamines; Humans; Mental Disorders; Psychoses, Subst | 1959 |
A case of recurrent psychosis associated with amphetamine addiction.
Topics: Amphetamine; Amphetamine-Related Disorders; Amphetamines; Humans; Mental Disorders; Psychotic Disord | 1950 |
[Contribution to the knowledge of pervitin psychoses].
Topics: Amphetamine; Humans; Mental Disorders; Paranoid Disorders; Psychotic Disorders | 1951 |
Acute psychosis caused by dextro-amphetamine.
Topics: Amphetamine; Amphetamines; Dextroamphetamine; Humans; Psychotic Disorders | 1949 |
[Psychotic manifestations of pervitin abuse].
Topics: Amphetamine; Humans; Mental Disorders; Psychotic Disorders; Substance-Related Disorders | 1950 |
[Psychotic manifestations of chronic pervitin abuse].
Topics: Amphetamine; Humans; Mental Disorders; Psychotic Disorders; Substance-Related Disorders | 1950 |
[Action of amphetamines in states of manic excitation; some paradoxical effects].
Topics: Amphetamine; Amphetamines; Bipolar Disorder; Humans; Psychotic Disorders | 1950 |
Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
Topics: Amphetamine; Amphetamines; Animals; Apomorphine; Behavior, Animal; Cues; Discrimination Learning; Do | 2005 |
Cinnarizine has an atypical antipsychotic profile in animal models of psychosis.
Topics: Amphetamine; Animals; Antipsychotic Agents; Calcium Channel Blockers; Catalepsy; Central Nervous Sys | 2005 |
Linking animal models of psychosis to computational models of dopamine function.
Topics: Action Potentials; Amphetamine; Animals; Computer Simulation; Conditioning, Classical; Disease Model | 2007 |
Beta-amyloid treatment sensitizes mice to amphetamine-induced locomotion but reduces response to caffeine.
Topics: Adenosine; Adrenergic Agents; Alzheimer Disease; Amphetamine; Amyloid beta-Peptides; Animals; Avoida | 2004 |
Priapism and quetiapine: a case report.
Topics: Amphetamine; Amphetamine-Related Disorders; Antipsychotic Agents; Comorbidity; Depressive Disorder; | 2006 |
ST2472: a new potential antipsychotic with very low liability to induce side-effects.
Topics: Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Anim | 2008 |
Benzedrine-derived psychosis.
Topics: Amphetamine; Amphetamines; Humans; Mental Disorders; Psychotic Disorders | 1948 |
Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity.
Topics: Amphetamine; Animals; Antipsychotic Agents; Arousal; Brain; Disease Models, Animal; Dopamine; Dose-R | 2008 |
Clinical trial of a new type promptly acting psychoenergetic agent (phenyl-isopropyl-methylpropinyl-HCl, "E-250").
Topics: Adult; Amphetamine; Animals; Depression; Dogs; Female; Humans; Male; Middle Aged; Monoamine Oxidase | 1967 |
Behavioural analysis of feeding: implications for the pharmacological manipulation of food intake in animals and man.
Topics: Amphetamine; Animals; Antipsychotic Agents; Appetite Depressants; Body Weight; Eating; Feeding Behav | 1980 |
Developments in biological psychiatry: clinical applications to the major psychoses.
Topics: Amphetamine; Antidepressive Agents; Depressive Disorder; Dexamethasone; Diagnosis, Differential; Hum | 1982 |
Limbic ictus and atypical psychoses.
Topics: Amphetamine; Animals; Carbamazepine; Cocaine; Electric Stimulation; Electroencephalography; Epilepsy | 1982 |
Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys.
Topics: Amphetamine; Animals; Disease Models, Animal; Female; Hallucinogens; Hydrocortisone; Macaca mulatta; | 1999 |
NMDA receptor antagonists acting at the glycineB site in rat models for antipsychotic-like activity.
Topics: 2-Amino-5-phosphonovalerate; Amphetamine; Animals; Antimetabolites; Antipsychotic Agents; Binding Si | 1999 |
Behavioural and anti-psychotic effects of Ca2+ channel blockers in rhesus monkey.
Topics: Amphetamine; Animals; Behavior, Animal; Calcium Channel Blockers; Central Nervous System Stimulants; | 2001 |
The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans.
Topics: Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Benzamides; Carrier Proteins; Coc | 2001 |
Differential effects of amphetamine and phencyclidine on the expression of growth-associated protein GAP-43.
Topics: Amphetamine; Animals; Biomarkers; Brain; Disease Models, Animal; Dopamine Agents; Dopamine Antagonis | 2001 |
Hair analysis for cannabinoids and amphetamines in a psychosis incidence study.
Topics: Adult; Amphetamine; Cannabinoids; Confidence Intervals; Dopamine Agents; Female; Gas Chromatography- | 2002 |
Neuroleptic interference with the cocaine cue: internal stimulus control of behavior and psychosis.
Topics: Amphetamine; Animals; Antipsychotic Agents; Behavior; Cocaine; Cues; Drug Interactions; Haloperidol; | 1978 |
Amphetamine psychosis and psychotic symptoms.
Topics: Amphetamine; Humans; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Psychotic Disor | 1979 |
Psychotropic drugs in the management of psychiatric emergencies.
Topics: Administration, Oral; Amphetamine; Chlorpromazine; Hallucinogens; Haloperidol; Humans; Hypotension; | 1975 |
Prolonged cocaine psychosis implies underlying major psychopathology.
Topics: Amphetamine; Cocaine; Humans; Male; Paranoid Disorders; Psychoses, Substance-Induced; Psychotic Diso | 1991 |
Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.
Topics: Adolescent; Adult; Alcoholism; Amphetamine; Cross-Sectional Studies; Female; Humans; Incidence; Male | 1990 |
Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Benzimidazoles; Blepharoptosis; Body Temperatur | 1968 |
Psychiatric disorders affecting civil aircrew in the fifth and sixth decades.
Topics: Aerospace Medicine; Age Factors; Alcoholism; Amphetamine; Antidepressive Agents; Central Nervous Sys | 1970 |
[Genetic factors in the recurrent confusional psychoses].
Topics: Amphetamine; Bipolar Disorder; Cognition Disorders; Humans; Lysergic Acid Diethylamide; Mental Proce | 1972 |
A dopaminergic-cholinergic mechanism in production of psychotic symptoms.
Topics: Amphetamine; Animals; Brain; Brain Chemistry; Dopamine; Humans; Models, Biological; Parasympatholyti | 1973 |
The life course of children with schizophrenia.
Topics: Amphetamine; Anticonvulsants; Autistic Disorder; Barbiturates; Child; Child, Preschool; Culture; Fam | 1973 |
[Psychiatric emergencies during pregnancy and in the puerperium].
Topics: Amphetamine; Cannabis; Emergencies; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Lyse | 1973 |
[Neurochemical mechanisms of formation of psychopathologic conditions due to emotional stress].
Topics: Amphetamine; Animals; Brain; Cerebral Cortex; Chlorpromazine; Electroencephalography; Electromyograp | 1973 |
Drug abuse and psychiatric hospitalization: urine examination in admissions.
Topics: Adolescent; Adult; Amphetamine; Barbiturates; Chromatography, Gas; Chromatography, Thin Layer; Czech | 1972 |
A third case of self-enucleation.
Topics: Adult; Amphetamine; Eye Injuries; Female; Guilt; Hallucinogens; Humans; Psychoses, Substance-Induced | 1972 |
Acute psychosis induced by psychotomimetic drug abuse. I. Clinical findings.
Topics: Acute Disease; Adolescent; Adult; Amphetamine; Delusions; Diagnosis, Differential; Female; Hallucino | 1972 |
[Limits of biological therapy in child psychiatry].
Topics: Adolescent; Amphetamine; Barbiturates; Child; Child, Preschool; Enuresis; Fear; Feeding and Eating D | 1966 |
A survey of the research of department E.
Topics: Amphetamine; Animals; Catecholamines; Chlorpromazine; Denmark; Hospitals, Psychiatric; Humans; Monoa | 1966 |
Drug use in adolescents. Psychodynamic meaning and pharmacogenic effect.
Topics: Adolescent; Adolescent Psychiatry; Adult; Alcoholism; Amphetamine; Cannabis; Ego; Female; Heroin; Ho | 1969 |
[Subclinical sleep activity in the EEG].
Topics: Adult; Amphetamine; Arousal; Brain Diseases; Cataplexy; Child; Child Behavior Disorders; Electroence | 1969 |
[Psychohygienic aspects of drug dependence and alcohol abuse].
Topics: Alcoholism; Amphetamine; Barbiturates; Benzazepines; Drug and Narcotic Control; Female; Humans; Male | 1969 |
[Oniropriva psychoses and their biologic treatment].
Topics: Adjustment Disorders; Amphetamine; Antidepressive Agents; Barbiturates; Dreams; Electroconvulsive Th | 1969 |
[Oniropriva psychoses and their biologic treatment].
Topics: Adjustment Disorders; Amphetamine; Antidepressive Agents; Barbiturates; Dreams; Electroconvulsive Th | 1969 |
Investigation of p-methoxyamphetamine excretion in amphetamine induced psychosis.
Topics: Amphetamine; Humans; Methylation; Psychoses, Substance-Induced; Psychotic Disorders | 1970 |
Definition and classification of neuroleptics.
Topics: Amphetamine; Animals; Apomorphine; Autonomic Nervous System; Basal Ganglia Diseases; Behavior; Catal | 1970 |
The neuroleptics. 3. Pharmacology. Introduction.
Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior; Behavior, Animal; Blepharoptosis; B | 1970 |
Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction.
Topics: Amphetamine; Animals; Apomorphine; Behavior; Behavior, Animal; Corpus Striatum; Dopamine; Dopamine A | 1970 |
Morbidity and mortality from heroin dependence. 2. Study of 100 consecutive inpatients.
Topics: Adolescent; Adult; Alcoholism; Amphetamine; Barbiturates; Cannabis; Cocaine; Hepatitis A; Hepatitis | 1968 |
[Hallucinosis in ephedrine addiction].
Topics: Adult; Amphetamine; Anxiety; Ephedrine; Euphoria; Female; Hallucinations; Humans; Mental Disorders; | 1968 |
Behavioural models of psychosis.
Topics: Amines; Amphetamine; Animals; Avoidance Learning; Brain Chemistry; Chemistry, Pharmaceutical; Chlorp | 1969 |
An analysis of urinary amine values on routine admissions to a mental hospital.
Topics: Amines; Amitriptyline; Amphetamine; Chemical Phenomena; Chemistry; Chlorpromazine; Humans; In Vitro | 1965 |
Psychiatric complications of amphetamine substances.
Topics: Adolescent; Adult; Amitriptyline; Amphetamine; Chlordiazepoxide; Depression; Ephedrine; Female; Hall | 1966 |